TORII PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,855 JPY | +1.72% |
|
+4.47% | +8.44% |
| 02-13 | LIM Advisors Partially Withdraws Shareholder Proposal | CI |
| 02-09 | Torii Pharmaceuticals Opposes Shareholder Proposal | CI |
| Sales 2024 * | 57.8B 365M 499M | Sales 2025 * | 61.22B 386M 528M | Capitalization | 108B 683M 934M |
|---|---|---|---|---|---|
| Net income 2024 * | 4.88B 30.84M 42.15M | Net income 2025 * | 5.65B 35.69M 48.78M | EV / Sales 2024 * | 1.87 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.77 x |
| P/E ratio 2024 * |
22.2
x | P/E ratio 2025 * |
19.2
x | Employees | 583 |
| Yield 2024 * |
3.11% | Yield 2025 * |
3.11% | Free-Float | 42.17% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.72% | ||
| 1 week | +4.47% | ||
| Current month | -5.86% | ||
| 1 month | -6.77% | ||
| 3 months | +1.98% | ||
| 6 months | +5.33% | ||
| Current year | +8.44% |
1 week
3 705.00
3 880.00
1 month
3 645.004 160.00
Current year
3 540.004 370.00
1 year
3 275.004 370.00
3 years
2 322.004 370.00
5 years
2 129.004 370.00
10 years
1 981.004 370.00
| Managers | Title | Age | Since |
|---|---|---|---|
Goichi Matsuda
PSD | President | 57 | 17-02-28 |
| Director of Finance/CFO | - | - | |
Megumi Kajiwara
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | 60 | 87-03-31 | |
Masao Torikai
BRD | Director/Board Member | 61 | 10-05-31 |
Masaki Sunami
PRN | Corporate Officer/Principal | 65 | 14-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.12% | 15 M€ | +7.34% | ||
| 0.05% | 2 M€ | -.--% | ||
| 0.02% | 7 M€ | -.--% | - | |
| 0.01% | 18 M€ | +16.15% | - | |
| 0.01% | 20,721 M€ | +13.52% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 3,855 | +1.72% | 48,200 |
| 24-04-25 | 3,790 | +0.80% | 39,500 |
| 24-04-24 | 3,760 | -0.53% | 18,900 |
| 24-04-23 | 3,780 | +0.40% | 14,900 |
| 24-04-22 | 3,765 | +2.03% | 20,100 |
Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am
More quotes
TORII PHARMACEUTICAL CO., LTD. is mainly engaged in the manufacture and sale of pharmaceutical products. The Companyâs main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Companyâs main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.
Sector
Pharmaceuticals
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.44% | 688M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 4551 Stock
